DCM
Daruma Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-177,242
| Closed | -$6.75M | – | 22 |
|
|
2019
Q1 | $6.75M | Sell |
177,242
-282,319
| -61% | -$10.7M | 0.77% | 32 |
|
|
2018
Q4 | $19.8M | Sell |
459,561
-48,079
| -9% | -$2.07M | 2.63% | 20 |
|
|
2018
Q3 | $25M | Sell |
507,640
-673,610
| -57% | -$33.1M | 2.35% | 26 |
|
|
2018
Q2 | $37.9M | Buy |
1,181,250
+44,030
| +4% | +$1.41M | 2.46% | 25 |
|
|
2018
Q1 | $35.4M | Sell |
1,137,220
-93,634
| -8% | -$2.92M | 2.21% | 28 |
|
|
2017
Q4 | $56.2M | Buy |
1,230,854
+8,199
| +0.7% | +$374K | 3.5% | 12 |
|
|
2017
Q3 | $45.9M | Buy |
1,222,655
+100,730
| +9% | +$3.78M | 2.86% | 22 |
|
|
2017
Q2 | $53.5M | Sell |
1,121,925
-36,774
| -3% | -$1.75M | 3.19% | 11 |
|
|
2017
Q1 | $52.8M | Sell |
1,158,699
-60,943
| -5% | -$2.78M | 3.08% | 15 |
|
|
2016
Q4 | $39.4M | Sell |
1,219,642
-402
| -0% | -$13K | 2.24% | 28 |
|
|
2016
Q3 | $41.8M | Buy |
1,220,044
+143,320
| +13% | +$4.9M | 2.55% | 25 |
|
|
2016
Q2 | $36.3M | Buy |
1,076,724
+113,540
| +12% | +$3.83M | 2.37% | 27 |
|
|
2016
Q1 | $51M | Buy |
963,184
+14,901
| +2% | +$789K | 3.19% | 18 |
|
|
2015
Q4 | $72.8M | Sell |
948,283
-93,729
| -9% | -$7.2M | 4.36% | 1 |
|
|
2015
Q3 | $42.8M | Buy |
1,042,012
+374,135
| +56% | +$15.4M | 2.63% | 26 |
|
|
2015
Q2 | $47.2M | Buy |
667,877
+7,879
| +1% | +$557K | 2.07% | 29 |
|
|
2015
Q1 | $58.6M | Sell |
659,998
-29,630
| -4% | -$2.63M | 2.62% | 26 |
|
|
2014
Q4 | $61.1M | Sell |
689,628
-124,842
| -15% | -$11.1M | 2.66% | 26 |
|
|
2014
Q3 | $78.9M | Sell |
814,470
-318,082
| -28% | -$30.8M | 3.47% | 2 |
|
|
2014
Q2 | $104M | Sell |
1,132,552
-238,490
| -17% | -$21.9M | 4.26% | 1 |
|
|
2014
Q1 | $96M | Buy |
1,371,042
+66,852
| +5% | +$4.68M | 3.81% | 1 |
|
|
2013
Q4 | $75M | Buy |
1,304,190
+874,502
| +204% | +$50.3M | 3.11% | 14 |
|
|
2013
Q3 | $20.7M | Buy |
429,688
+418,706
| +3,813% | +$20.1M | 0.95% | 34 |
|
|
2013
Q2 | $318K | Buy |
+10,982
| New | +$318K | 0.02% | 64 |
|